Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions

Journal of the American College of Cardiology

Volumn 41, Issue 10, 2003, Pages 1725-1731

  Costantini, Costantino O ^a   Lansky, Alexandra J ^a,c   Mintz, Gary S ^a   Shirai, Kazuyuki ^a   Dangas, George ^a   Mehran, Roxana ^a   Fahy, Martin ^a   Slack, Steven ^a   Coral, Maria ^a   Teirstein, Paul S ^a   Waksman, Ron ^b   Stone, Gregg ^a   Moses, Jeffrey ^a   Leon, Martin B ^a  

^a LENOX HILL HOSPITAL   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ARTICLE; BETA RADIATION; BRACHYTHERAPY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DATA BASE; GAMMA RADIATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RESTENOSIS;

EID: 0037902150     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00298-5     Document Type: Article

References (32)

1. Mathias DW, Mooney JF, Lange HW, Goldenberg IF, Gobel FL, Mooney MR. Frequency of success and complications of coronary angioplasty of a stenosis at the ostium of a branch vessel. Am J Cardiol 1991;67:491-5.
2. Kereiakes DJ. Percutaneous transcatheter therapy of aorto-ostial stenoses. Cathet Cardiovasc Diagn 1996;38:292-300.
3. Zampieri P, Colombo A, Almagor Y, Maiello L, Finci L. Results of coronary stenting of ostial lesions. Am J Cardiol 1994;73:901-3.
4. Tan RP, Kini A, Shalouh E, Marmur JD, Sharma SK. Optimal treatment of non-aorto-ostial coronary lesions in large vessels: acute and long-term results. Catheter Cardiovasc Interv 2001;54:283-8.
5. Safian RD, Freed M, Reddy V, et al. Do excimer laser angioplasty and rotational atherectomy facilitate balloon angioplasty? Implications for lesion-specific coronary intervention. J Am Coll Cardiol 1996;27:552-9.
6. Colombo A, Ferraro M, Itoh A, Martini G, Blengino S, Finci L. Results of coronary stenting for restenosis. J Am Coll Cardiol 1996;28:830-6.
7. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-8.
8. Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-6.
9. Waksman R, White RL, Chan RC, et al. Intracoronary gamma-radiation therapy inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-71.
10. Ajani AE, Kim HS, Waksman R. Clinical trials of vascular brachytherapy for in-stent restenosis: update. In: Waksman R, editor. Vascular Brachytherapy. 3rd edition. Armonk, NY: Futura Publishing Co. Inc., 2002:651-63.
11. Elliot KW, Walsh RP, diMonda R. Novoste Beta-cath system: intracoronary radiation with strontium 90. In: Waksman R, editor. Vascular Brachytherapy. 3rd edition. Armonk, NY: Futura Publishing Co. Inc., 2002:717-27.
12. Suntharalingam M, Laskey W, Lansky AJ, Waksman R, White L, Teirstien P. Clinical and angiographic outcomes after use of 90 strontium/90 yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys 2002;52:1075-82.
13. Lansky AJ, Popma JJ. Qualitative and quantitative angiography. In: Topol EJ, editor. Textbook of Interventional Cardiology. Philadelphia, PA: W.B. Saunders Company, 1999:725-45.
14. Lansky AJ, Dangas G, Mehran R, et al. Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. J Am Coll Cardiol 2002;39:274-80.
15. Lansky AJ, Desai KJ, Bonan R, Koning G, Tuinenburg J, Reiber J. Quantitative coronary angiography methodology in vascular brachytherapy II. In: Waksman R, editor. Vascular Brachytherapy, 3rd edition. Armonk, NY: Futura Publishing Co. Inc., 2002:543-62.
16. Reiber J. Why and how should QCA systems should be validated? In: Serruys PW, Foley DP, de Feyter PJ, editors. Quantitative Coronary Angiography in Clinical Practice. The Netherlands: Kluwer Academic Publishers, 1994.
17. Reiber J, Van Der Zwet PMJ, Koning G, et al. Accuracy and precision of quantitative digital coronary arteriography; observer-, as well as short- and medium-term variabilities. In: Serruys PW, Foley DP, de Feyter PJ, editors. Quantitative Coronary Angiography in Clinical Practice. The Netherlands: Kluwer Academic Publishers, 1994.
18. Reiber JH, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985;71:280-8.
19. Herrington DM, Siebes M, Sokol DK, Siu CO, Walford GD. Variability in measures of coronary lumen dimensions using quantitative coronary angiography. J Am Coll Cardiol 1993;22:1068-74.
20. Ahmed JM, Mintz GS, Waksman R, et al. Serial intravascular ultrasound analysis of edge recurrence after intracoronary gamma radiation treatment of native artery in-stent restenosis lesions. Am J Cardiol 2001;87:1145-9.
21. 32P radioactive beta-emitting stents. Circulation 2000;101:2454-7.
22. Kimball BP, Bui S. Comparative analysis of saphenous vein bypass vs. native coronary artery balloon angioplasty: technical differences and angiographic response. Cathet Cardiovasc Diagn 1995;34:293-9; discussion 300.
23. Bauters C, Banos JL, Van Belle E, McFadden EP, Lablanche JM, Bertrand ME. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation 1998;97:318-21.
24. vom Dahl J, Dietz U, Haager PK, et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 2002;105:583-8.
25. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002;359:551-7.
26. Malhotra S, Teirstein PS. The SCRIPPS trial - catheter-based radiotherapy to inhibit coronary restenosis. J Invasive Cardiol 2000;12:330-2.
27. Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997;95:1366-9.
28. Moses JW, Moussa I, Leon MB, et al. Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (sub-analysis of the GAMMA-I randomized trial). Am J Cardiol 2002;90:243-7.
29. Sabate M, Costa MA, Kozuma K, et al. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation 2000;101:2467-71.
30. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105-12.
31. Cottin Y, Lansky AJ, Kim HS, et al. Intracoronary brachytherapy not associated with changes in major side branches. Catheter Cardiovasc Interv 2000;51:154-8.
32. Naber C, Alkhani M, Brauck K, et al. Intracoronary brachytherapy for in-stent restenosis: eliminating the side branches (abstr)? J Am Coll Cardiol 2002;39:23A.